BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 26603365)

  • 1. Limb-threatening Deep Venous Thrombosis Complicating Warfarin Reversal with Three-factor Prothrombin Complex Concentrate: A Case Report.
    Jablow LM; Jones CW; Carroll GG; Wilsey SV; Haroz R
    J Emerg Med; 2016 Jan; 50(1):28-31. PubMed ID: 26603365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of Venous Thromboembolism After Receiving Prothrombin Complex Concentrate for Warfarin-associated Intracranial Hemorrhage.
    Felton D; Foley EM; Traub SJ; Vodonos A; Ganetsky M
    J Emerg Med; 2016 Jan; 50(1):1-6. PubMed ID: 26409668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombotic complications following the administration of high-dose prothrombin complex concentrate for acute warfarin reversal.
    Zemrak WR; Kelley E; Kovacic NL; Mooney DM; Morris JG; MacVane CZ; Rosenblatt JA
    Am J Emerg Med; 2016 Aug; 34(8):1736.e1-3. PubMed ID: 26806175
    [No Abstract]   [Full Text] [Related]  

  • 4. Bilateral Phlegmasia Cerulea Dolens After Warfarin Reversal for Acute Rectal Bleeding: A Case Report.
    Fong B; Novak D; Dalley M; Alfred G
    J Emerg Med; 2018 Apr; 54(4):533-536. PubMed ID: 29449120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Warfarin Reversal with 4-Factor Prothrombin Complex Concentrate Compared to 3-Factor Prothrombin Complex Concentrate at a Tertiary Academic Medical Center.
    Al-Majzoub O; Rybak E; Reardon DP; Krause P; Connors JM
    J Emerg Med; 2016 Jan; 50(1):7-13. PubMed ID: 26433428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Four-factor prothrombin complex concentrate for life-threatening bleeds or emergent surgery: A retrospective evaluation.
    Sin JH; Berger K; Lesch CA
    J Crit Care; 2016 Dec; 36():166-172. PubMed ID: 27546767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prothrombin complex concentrates to reverse warfarin-induced coagulopathy in patients with intracranial bleeding.
    Cabral KP; Fraser GL; Duprey J; Gibbons BA; Hayes T; Florman JE; Seder DB
    Clin Neurol Neurosurg; 2013 Jun; 115(6):770-4. PubMed ID: 22835715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modeling the cost-effectiveness of prothrombin complex concentrate compared with fresh frozen plasma in emergency warfarin reversal in the United kingdom.
    Guest JF; Watson HG; Limaye S
    Clin Ther; 2010 Dec; 32(14):2478-93. PubMed ID: 21353116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thromboembolic Risk of 4-Factor Prothrombin Complex Concentrate versus Fresh Frozen Plasma for Urgent Warfarin Reversal in the Emergency Department.
    Maguire M; Fuh L; Goldstein JN; Marshall AL; Levine M; Howell ML; Parry BA; Rosovsky R; Hayes BD
    West J Emerg Med; 2019 Jul; 20(4):619-625. PubMed ID: 31316701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 4-Factor Prothrombin Complex Concentrate Administration via Intraosseous Access for Urgent Reversal of Warfarin.
    Peyko V; Shams D; Urbanski R; Noga J
    J Emerg Med; 2019 Jul; 57(1):82-84. PubMed ID: 31060844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protocolized warfarin reversal with 4-factor prothrombin complex concentrate versus 3-factor prothrombin complex concentrate with recombinant factor VIIa.
    Barton CA; Hom M; Johnson NB; Case J; Ran R; Schreiber M
    Am J Surg; 2018 May; 215(5):775-779. PubMed ID: 29338845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative effectiveness of 3- versus 4-factor prothrombin complex concentrate for emergent warfarin reversal.
    Voils SA; Holder MC; Premraj S; Catlin JR; Allen BR
    Thromb Res; 2015 Sep; 136(3):595-8. PubMed ID: 26233569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Four-factor Prothrombin Complex Concentrate for Reversal of Factor Xa Inhibitors versus Warfarin in Life-threatening Bleeding.
    Rech MA; Masic D; Hammond DA
    West J Emerg Med; 2021 Feb; 22(2):163-169. PubMed ID: 33856296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and Efficacy of Warfarin Reversal with Four-Factor Prothrombin Complex Concentrate for Subtherapeutic INR in Intracerebral Hemorrhage.
    Rivosecchi RM; Durkin J; Okonkwo DO; Molyneaux BJ
    Neurocrit Care; 2016 Dec; 25(3):359-364. PubMed ID: 27076286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experiences with an activated 4-factor prothrombin complex concentrate (FEIBA) for reversal of warfarin-related bleeding.
    Stewart WS; Pettit H
    Am J Emerg Med; 2013 Aug; 31(8):1251-4. PubMed ID: 23763937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Periprocedural warfarin reversal with prothrombin complex concentrate.
    Sridharan M; Wysokinski WE; Pruthi R; Oyen L; Freeman WD; Rabinstein AA; McBane RD
    Thromb Res; 2016 Mar; 139():160-5. PubMed ID: 26657301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimal dose of prothrombin complex concentrate for acute reversal of oral anticoagulation.
    Yasaka M; Sakata T; Naritomi H; Minematsu K
    Thromb Res; 2005; 115(6):455-9. PubMed ID: 15792675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Warfarin-induced bleeding complications - clinical presentation and therapeutic options.
    Wiedermann CJ; Stockner I
    Thromb Res; 2008; 122 Suppl 2():S13-8. PubMed ID: 18549907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Race against the clock: overcoming challenges in the management of anticoagulant-associated intracerebral hemorrhage.
    Le Roux P; Pollack CV; Milan M; Schaefer A
    J Neurosurg; 2014 Aug; 121 Suppl():1-20. PubMed ID: 25081496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term efficacy and safety of once-daily enoxaparin plus warfarin for the outpatient ambulatory treatment of lower-limb deep vein thrombosis in the TROMBOTEK trial.
    Kurtoglu M; Koksoy C; Hasan E; Akcalı Y; Karabay O; Filizcan U;
    J Vasc Surg; 2010 Nov; 52(5):1262-70. PubMed ID: 20732787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.